General Information of the Compound
| Compound ID |
CP0069431
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
US9206139, 5
Show/Hide
|
||||||||||||||||||
| Synonyms |
BDBM194646
CHEMBL3972836
SCHEMBL15692518
US9206139, 5
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H22F3N3O3
|
||||||||||||||||||
| Molecular Weight |
397.397
|
||||||||||||||||||
| Canonical SMILES |
CC(C)(Cc1ccc(cc1)C(F)(F)F)C(=O)NC[C@]1(NC(=O)NC1=O)C1CC1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H22F3N3O3/c1-17(2,9-11-3-5-13(6-4-11)19(20,21)22)14(26)23-10-18(12-7-8-12)15(27)24-16(28)25-18/h3-6,12H,7-10H2,1-2H3,(H,23,26)(H2,24,25,27,28)/t18-/m0/s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
FJEJHTFPLBTMLO-SFHVURJKSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00842, 72 kDa type IV collagenase
Protein ID: PT01276, Collagenase 3
Protein ID: PT00848, Interstitial collagenase
Protein ID: PT00964, Macrophage metalloelastase
Protein ID: PT00950, Matrilysin
Protein ID: PT00968, Matrix metalloproteinase-14
Protein ID: PT00849, Matrix metalloproteinase-9
Protein ID: PT00900, Neutrophil collagenase
Protein ID: PT00866, Stromelysin-1
Clinical Information about the Compound